Talaga-Ćwiertnia K, Krzyściak P, Bulanda M. Do bacteria isolated from ICU patients ‘ESKAPE’ antibiotic treatment? In vitro susceptibility of the Enterobacteriaceae family to tigecycline. Anestezjologia Intensywna Terapia. 2017:216-220.
APA
Talaga-Ćwiertnia, K., Krzyściak, P., & Bulanda, M. (2017). Do bacteria isolated from ICU patients ‘ESKAPE’ antibiotic treatment? In vitro susceptibility of the Enterobacteriaceae family to tigecycline. Anestezjologia Intensywna Terapia, 216-220.
Chicago
Talaga-Ćwiertnia, Katarzyna, Paweł Krzyściak, and Małgorzata Bulanda. 2017. "Do bacteria isolated from ICU patients ‘ESKAPE’ antibiotic treatment? In vitro susceptibility of the Enterobacteriaceae family to tigecycline". Anestezjologia Intensywna Terapia: 216-220.
Harvard
Talaga-Ćwiertnia, K., Krzyściak, P., and Bulanda, M. (2017). Do bacteria isolated from ICU patients ‘ESKAPE’ antibiotic treatment? In vitro susceptibility of the Enterobacteriaceae family to tigecycline. Anestezjologia Intensywna Terapia, pp.216-220.
MLA
Talaga-Ćwiertnia, Katarzyna et al. "Do bacteria isolated from ICU patients ‘ESKAPE’ antibiotic treatment? In vitro susceptibility of the Enterobacteriaceae family to tigecycline." Anestezjologia Intensywna Terapia, 2017, pp. 216-220.
Vancouver
Talaga-Ćwiertnia K, Krzyściak P, Bulanda M. Do bacteria isolated from ICU patients ‘ESKAPE’ antibiotic treatment? In vitro susceptibility of the Enterobacteriaceae family to tigecycline. Anestezjologia Intensywna Terapia. 2017:216-220.
This is an Open Access journal, all articles are distributed under the
terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC
BY-NC-SA
4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to
copy
and redistribute the material in any medium or format and to remix, transform, and build upon
the
material, provided the original work is properly cited and states its license.
